These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 19296764

  • 1. Diabetes and hypertension: which is the best approach?
    Escobar C, Barrios V.
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):269-71. PubMed ID: 19296764
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].
    van den Meiracker AH, van Montfrans GA.
    Ned Tijdschr Geneeskd; 2006 Apr 22; 150(16):886-8. PubMed ID: 16686086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Prevention of cardiovascular events by the antihypertensive treatment using amlodipine and perindopril in comparison with the use of atenolol and bendroflumethiazide. The ASCOT (Anglo-Scandinavian Outcomes Trail: blood pressure lowering arm) study results--multicentre, randomised, controlled trial. Landmark in the development of opinions on combination therapy in hypertension? (comment)].
    Widimský J.
    Vnitr Lek; 2005 Dec 22; 51(12):1394-6, 1398-9. PubMed ID: 16430107
    [Abstract] [Full Text] [Related]

  • 6. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
    Poulter NR, Dobson JE, Sever PS, Dahlöf B, Wedel H, Campbell NR, ASCOT Investigators.
    J Am Coll Cardiol; 2009 Sep 22; 54(13):1154-61. PubMed ID: 19761936
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
    Ostergren J, Poulter NR, Sever PS, Dahlöf B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, ASCOT investigators.
    J Hypertens; 2008 Nov 22; 26(11):2103-11. PubMed ID: 18854748
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E, Stanton AV, Thom S, Caulfield M, Atkins N, McInnes G, Collier D, Dicker P, O'Brien E, ASCOT Investigators.
    J Hypertens; 2009 Apr 22; 27(4):876-85. PubMed ID: 19516185
    [Abstract] [Full Text] [Related]

  • 13. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
    Gupta AK, Dahlof B, Dobson J, Sever PS, Wedel H, Poulter NR, Anglo-Scandinavian Cardiac Outcomes Trial Investigators.
    Diabetes Care; 2008 May 22; 31(5):982-8. PubMed ID: 18235048
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evidence-based treatment of hypertension in type 2-diabetes. New studies support active blood pressure reduction].
    Nilsson P.
    Lakartidningen; 2000 Feb 09; 97(6):568-72. PubMed ID: 10707481
    [Abstract] [Full Text] [Related]

  • 16. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
    Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B, ASCOT trial investigators.
    Heart; 2008 Feb 09; 94(2):e4. PubMed ID: 17916665
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR, Zappe D, Orloski LA, Sowers JR.
    J Hum Hypertens; 2011 Apr 09; 25(4):211-7. PubMed ID: 20596060
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of isolated systolic hypertension in diabetes mellitus type 2.
    Os I, Gudmundsdottir H, Kjeldsen SE, Oparil S.
    Diabetes Obes Metab; 2006 Jul 09; 8(4):381-7. PubMed ID: 16776744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.